Prestige Consumer Healthcare Inc. — Form 10-Q Summary
Business context and reporting period. This filing covers the quarter and six months ended September 30, 2019, in fiscal 2020. Prestige sells OTC healthcare products in North America and international markets. The Household Cleaning segment was sold on July 2, 2018, so the six-month comparison includes that segment’s sales in the prior-year period but not the current period.
Financial performance
| Metric | Three months ended Sept. 30, 2019 | Three months ended Sept. 30, 2018 | Six months ended Sept. 30, 2019 | Six months ended Sept. 30, 2018 |
|---|---|---|---|---|
| Total revenue | $238.1 million | $239.4 million | $470.2 million | $493.3 million |
| Gross profit | $136.8 million | $137.5 million | $270.8 million | $278.1 million |
| Operating income | $69.3 million | $70.9 million | $140.8 million | $143.4 million |
| Net income | $33.3 million | $30.8 million | $67.2 million | $65.3 million |
| Diluted EPS | $0.65 | $0.59 | $1.31 | $1.24 |
| Cash from operations | Not provided for the quarter | $103.0 million | $95.1 million |
- Quarterly revenue decreased 0.5%; gross margin was 57.4%, unchanged from the prior-year quarter. Net income rose about 7.8%, while operating income declined about 2.2%.
- Six-month revenue declined 4.7%, mainly reflecting the divested Household Cleaning business. Excluding that segment’s $19.8 million of prior-year revenue, OTC revenue decreased 0.7%.
- Six-month gross margin increased to 57.6% from 56.4%, partly because the divested segment had lower margins. North American OTC sales were pressured by retailer inventory reductions; International OTC revenue increased 6.4% for the six months, partly offset by unfavorable currency effects.
- Interest expense was $24.5 million for the quarter and $49.6 million for the six months, down from $27.1 million and $53.1 million, respectively. The company attributed the decline primarily to lower average indebtedness.
Financial position, liquidity and capital
- At September 30, 2019, cash was $27.9 million; current assets were $304.9 million and current liabilities were $146.9 million.
- Gross debt was $1.767 billion, versus $1.813 billion at March 31, 2019; the balance-sheet carrying value, net of debt costs, was $1.754 billion. Debt comprised $1.0 billion of senior notes, $738 million of term loans and $29 million drawn on the ABL revolver. The revolver had $125 million of additional borrowing capacity.
- Operating cash flow of $103.0 million exceeded capital expenditures of $5.8 million. Financing cash outflow was $96.3 million, including $50.0 million of share repurchases. Cash increased $0.4 million over the six months.
- Management said operating cash flow and existing credit facilities were expected to be adequate for working capital and capital expenditures over the next 12 months, excluding acquisitions. The company reported compliance with its debt covenants at quarter-end and anticipated continued compliance in the remainder of fiscal 2020.
Changes, outlook and risks
- Quarterly North American OTC revenue fell 1.0%; International OTC revenue rose 3.3%. Management cited retailer inventory reductions, foreign exchange, consumption growth and geographic expansion as contributing factors. Warehouse transition costs affected gross profit, while increased advertising and promotion weighed on North American contribution margin.
- No specific revenue or earnings guidance was provided. Management cautioned that six-month results are not necessarily indicative of full-year results.
- The company adopted the new lease accounting standard on April 1, 2019. At September 30, operating lease liabilities totaled $34.5 million; adoption did not affect other financial statements.
- Key risks include customer concentration (Walmart represented 22.9% of quarterly gross revenue), dependence on third-party manufacturers and logistics providers, retailer inventory practices, competition, foreign exchange and interest-rate exposure, and substantial debt. A 1 percentage-point increase in rates on variable-rate debt was estimated to reduce pre-tax earnings and cash flow by about $2.0 million for the quarter and $4.0 million for the six months.
- The company disclosed no material change to the risk factors in its prior annual report. It stated routine legal matters were not expected to have a material adverse effect, taking reserves into account. Goodwill and intangible assets were about $3.07 billion combined; management reported no impairment indicators at quarter-end.
Important facts for investors to verify
- Whether OTC sales trends and retailer inventory reductions improve, particularly in North America.
- Whether the warehouse and logistics-provider transition creates additional costs, delays or customer penalties.
- Debt repayment capacity, covenant headroom and exposure to variable interest rates; the filing does not provide a clear current leverage ratio.
- How the $50 million repurchase program and future capital allocation affect liquidity and share count.
- Whether the concentration of sales with Walmart and reliance on third-party manufacturers and logistics providers create operational or negotiating risks.